Apotex Mystery: Why Has Accord BioPharma Taken Its Place In Pegfilgrastim Biosimilar Litigation?

 
• By Brenda Sandburg

Court grants request to substitute Accord BioPharma for Apotex in Amgen infringement suit. Apotex says it has no plans to exit the biosimilar business.

Substitute-Player
Apotex has Accord BioPharma take its place in Amgen biosimilar suit

More from Biosimilars

More from Biosimilars & Generics